Psychiatr. pro Praxi, 2006; 1: 29-33

THE TREATMENT OF PSYCHOTIC DEPRESSION - ACUTE AND CONTINUATION DRUG TREATMENT

MUDr. Martin Bareš1, MUDr. Miloslav Kopeček Ph.D1,2
1 Psychiatrické centrum Praha, 3. LF UK, Praha
2 3. LF UK, Praha

The psychotic depression is relatively common type of depressive disorder. It is different from non – psychotic form of unipolar depression in certain characteristics (eg. response to treatment, risk of suicide, course and prognosis of illness etc.). Authors review efficacy of various pharmacological treatment of psychotic depression (tricyclic antidepressants, selective serotonin reuptake inhibitors, antipsychotics). The most effective pharmacological acute treatment of psychotic depression is according to results of clinical trials combination of antidepressant and antipsychotic. The use of atypical antipsychotics with selective serotonin reuptake inhibitors could be new promise in the treatment of psychotic depression. Guidelines for continuation treatment are not evidence – based, because controlled, double-blind study are lacking.

Keywords: Key words: psychotic depression, tricyclic antidepressants, 1st generation of antipsychotics, 2nd generation of antipsychotics, selective serotonin reuptake inhibitors, acute phase of treatment, continuation phase of treatment.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bareš M, Kopeček M. THE TREATMENT OF PSYCHOTIC DEPRESSION - ACUTE AND CONTINUATION DRUG TREATMENT. Psychiatr. praxi. 2006;7(1):29-33.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aronson TA, Shukla S, Gujavarty J, Hoff A, DiBuono M, Khan E. Relapse in delusional depression: A retrospective study of the course of treatment. Compr. Psychiatry 1988; 29: 12-21. Go to original source... Go to PubMed...
    2. Bareš M, Praško J. Depresivní porucha. In: eds. Seifertová D, Praško J, Höschl C. Postupy v léčbě psychických poruch. Academia Medica Pragensis 2004: Praha: pp. 67-91.
    3. Belini L, Gsaperini M, Gatti F, Franchini L, Smeraldi E. A double - blind study with fluvoxamine versus desimipramine combined with placebo or haloperidol in delusional depression. Preliminary results. In: Langer SZ, Brynelko N, Racagni G, Mendlewicz J (eds): Critical issues in the treatment of affective disorders. Int Acad Biomed Drug Res.1994; 9: 32-36.
    4. Birkenhäger TK, Pluijms EM, Lucius SAP. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disorder 2003; 74: 191-195. Go to original source... Go to PubMed...
    5. Bonomo V, Fogliani AM. Citalopram and haloperidol for psychotic depression. Am J Psychiatry 2000; 157: 1706-1707. Go to original source... Go to PubMed...
    6. Bruijn JA, Moleman P, Mulder PGH, van den Broek WW. Treatment of mood-congruent psychotic depression with imipramine. J Affect Disorder 2001; 66: 165-174. Go to original source... Go to PubMed...
    7. Bruijn JA, Moleman P, Mulder PHG, van der Broek WW, van Hulst AM, van der Mast RC, van de Wetering BJM. A double - blind, fixed blood - level study comparing mirtazapine with imipramine in depressed in-patients. Psychoharmacology 1996; 127: 231-237. Go to original source... Go to PubMed...
    8. Coryell W, Pfohl B, Zimmerman M. The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 1984; 172: 521-528. Go to original source... Go to PubMed...
    9. DeBattisa C, Rothschild AJ, Schatzberg AF. A dynamic algorithm for the treatment of psychotic major depression. Psychiatric Annals 2002; 32: 681-691. Go to original source...
    10. Ebert D. Lithium-TCA combination treatment of psychotic depression: Comparison with TCA - neuroleptice treatment. J Clin Psychopharmacol 1997; 17: 129-130. Go to original source... Go to PubMed...
    11. Flemming SK, Blasey C, Schatzberg AF. Neuropsychological correlates of psychotic features in major depressive disorders: A review and meta-analysis. Journal of Psychiatric Research 2004; 38: 27-35. Go to original source... Go to PubMed...
    12. Gatti F, Belini L, Gasperini M, Perez J, Zanardi R, Smeraldi E. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 1996; 153: 414-416. Go to original source... Go to PubMed...
    13. Hillert A., Maier W., Wetzel H., Benkert O.: Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - a functional approach. Pharmacopsychiatry 1992; 25: 213-217. Go to original source... Go to PubMed...
    14. Janicak PG, Pandey GN, Davis J., Boshes R, Bresnahan D, Sharma R. Response of psychotic and nonpsychotic depression to phenelzine. Am J Psychiatry 1988; 145: 93-95. Go to original source... Go to PubMed...
    15. Johnson J, Horwath E, Weissman MM. The validity of major depression with psychotic features based on community study. Arch Gen Psychiatry 1991; 42: 1145-1147. Go to original source... Go to PubMed...
    16. König F, Hippel C, Petersdorff T, Neuhöffer - Weiss M, Wolfersdorf M, Kaschka WP. First experiences in combination therapy using olanzapine with SSRIs (Citalopram, Paroxetine) in delusional depression. Pharmacopsychiatry 2001; 43: 170-174. Go to original source...
    17. Matthews JD, Bottonari BA, Polania LM, Mischoulon D, Sordiny CM, Irvin R, Fava M. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: Interim analysis. J Clin Psychiatry 2002; 63: 1164-1170. Go to original source... Go to PubMed...
    18. Meyers BC, Klimstra SA, Gabriele M, Hamilton M, Kakuma T, Tirumalasetti F, Alexopoulos GS. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 2001; 9: 415-422. Go to original source...
    19. Muller-Siecheneder F, Muller MJ, Hillert A, Szegedi A,Wetzel H, Benkert O. Risperidone versus haloperidol and amitriptyline in the treatment of patients with combined psychotic and depressive syndrome. J Clin Psychopharmacol 1998; 18: 111-120. Go to original source... Go to PubMed...
    20. Mulsant BH, Haskett RF, Prudic J. Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 1997; 154: 559-561. Go to original source... Go to PubMed...
    21. Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T et al. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptylinem plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 2001; 68: 597-604. Go to original source... Go to PubMed...
    22. Náhunek K, Rodová A, Švestka J, Kamenická V, Češková E, Mišurec J. Clinical experience with clozapine in endogenous depression. Activ nerv sup 1973; 15: 111.
    23. Nelson EB, McElroy SL. Psychotic depression. A guide to drug choice. CNS Drugs 1997; 6: 457-473. Go to original source...
    24. Parker G, Roy K, Hadzi-Pavlovic D, Pedic F. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disorder1992; 24:17-24. Go to original source... Go to PubMed...
    25. Petrides G, Fink M, Husain MM, Knapp RG, Rush JA, Mueller M et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17: 244-253. Go to original source... Go to PubMed...
    26. Ranjan R, Meltzer HY. Acute and long-term effectivness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 1996; 40: 253-258. Go to original source... Go to PubMed...
    27. Rothschild AJ, Duval SE. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry 2003; 64: 390-396. Go to original source... Go to PubMed...
    28. Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional depression. Am J Psychiatry 1999; 156: 977-988. Go to original source... Go to PubMed...
    29. Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 1993; 54: 338-342.
    30. Rothschild JA, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, van Campen LE, Sanger (tm), Tollefson GD. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004; 24: 365-373. Go to original source... Go to PubMed...
    31. Simpson GM, Sheshai AE, Rady A, Kingsbury SJ, Fayek M. Sertraline monotherapy in the treatment of psychotic and nonpsychotic depression. J Clin Psychiatry 2003; 64: 959-965. Go to original source... Go to PubMed...
    32. Spiker DG. Weiss JC, Dealy RS. The pharmacological treatment of delusional depression. Am J Psychiatry 1985; 142: 430-436. Go to original source... Go to PubMed...
    33. Texas Medical Algorithm Project. TMAP Table of contents Aug. 6, 2001. htpp://www.mhmr. state.tx.us/centraloffice/medicaldirector/tmaptoc.html.
    34. Thase ME. What role do atypical antipsychotic drugs have in treatment - resistant depression? J Clin Psychiatry 2002; 63: 95-103. Go to original source... Go to PubMed...
    35. Wolfersdorf M, Konig F, Barg T. Monotherapy of delusional depression with zotepin - results of a 28-day-monotherapy. Psychopharmakotherapie1997; 4: 149-152.
    36. Wolfersdorf M, Konig F, Straub R. Pharmacotherapy of delusional depression:experience with combinations of antidepressants with the neuroleptics zotepine and haloperidol. Pharmacopsychiatry 1994; 29: 189-193. Go to original source...
    37. Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996; 153: 1631-1633. Go to original source... Go to PubMed...
    38. Zanardi R, Franchini L, Gasperini M, Lucca A, Smeraldi E, Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: A controlled study. J Clin Psychopharmacol 1998; 18: 441-446. Go to original source... Go to PubMed...
    39. Zanardi R, Franchini L, Gasperini M, Smeraldi E, Perez J. Long - term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study. International Clinical Psychopharmacology 1997; 12: 195-197. Go to original source... Go to PubMed...
    40. Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E. Venlafaxine versus fluvoxamine in the treatment of delusional depression: A pilot doble-blind controlled study. J Clin Psychiatry 2000; 61: 26-29. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.